Long-term Outcomes of Metformin in Conjunction with Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer in a Prospective Phase II Clinical Trial

Authors

Molly Tate, The University of Texas MD Anderson Cancer Center

Files

Description

Molly Tate pictured.

Publication Date

2023

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Recommended Citation

Tate, Molly, "Long-term Outcomes of Metformin in Conjunction with Stereotactic Radiotherapy for Early-Stage Non-Small Cell Lung Cancer in a Prospective Phase II Clinical Trial" (2023). APRN Week 2023. 23.
https://openworks.mdanderson.org/aprn-week-23/23